GlassScriptPhysician profile
Melissa A Sutton
NPI 1528115755
$18,212.90
in general payments reported to CMS, 2019-2025
28 companies · $3,266 in 2025
The $3,266 reported for 2025 was more than what 97% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,832 · 2022: $1,459 · 2023: $3,634 · 2024: $8,022 · 2025: $3,266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,861 · Travel and Lodging: $3,692 · Consulting Fee: $3,328 · Education: $40.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,860.84 |
| Travel and Lodging | $3,692.48 |
| Consulting Fee | $3,327.50 |
| Education | $40.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $10,614.38 | 2021-2025 | Cardiomems, Aveir, Mitraclip |
| Edwards Lifesciences Corporation | $1,503.88 | 2021-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Novartis Pharmaceuticals Corporation | $1,083.50 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $725.54 | 2022-2025 | Verquvo, Capvaxive |
| Amgen INC. | $583.53 | 2021-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $558.21 | 2021-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $455.06 | 2021-2025 | Camzyos, Eliquis |
| Alnylam Pharmaceuticals INC. | $409.28 | 2021-2025 | Onpattro, Amvuttra |
| Janssen Pharmaceuticals, INC | $330.65 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $280.55 | 2021-2025 | Jardiance |
| Medtronic, INC. | $263.83 | 2021-2025 | Corevalve Evolut R, Symplicity G3 |
| Cvrx, INC. | $223.37 | 2025 | Barostim Neo System |
| Irhythm Technologies, INC. | $211.67 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| W. L. Gore & Associates, INC. | $156.92 | 2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Iliac Branch Endoprosthesis |
| Pfizer INC. | $146.56 | 2021-2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $137.59 | 2024 | |
| Itamar Medical INC | $103.05 | 2022-2024 | Watchpatone |
| Boston Scientific Corporation | $99.63 | 2022-2024 | Watchman Flx, Watchman Access System |
| Astrazeneca Pharmaceuticals LP | $87.20 | 2021-2024 | Farxiga, Lokelma |
| Bayer Healthcare Pharmaceuticals INC. | $64.46 | 2024-2025 | |
| Philips North America LLC | $41.47 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $41.04 | 2023 | Inpefa |
| Sanofi-Aventis U.S. LLC | $27.71 | 2021-2023 | |
| Teleflex LLC | $15.01 | 2025 | Guideliner V3 Catheter |
| Organogenesis INC. | $14.11 | 2024 | |
| Amarin Pharma, INC. | $13.81 | 2022 | |
| Arbor Pharmaceuticals, INC. | $13.27 | 2021 | |
| Altathera Pharmaceuticals LLC | $7.62 | 2025 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Sutton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.